Finch Therapeutics Group, Inc.

FNCH · OTC
Analyze with AI
6/30/2024
3/31/2024
12/31/2023
9/30/2023
Assets
Cash & Equivalents$16,035$20,762$25,124$28,779
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$1,244$413$723$1,140
Total Curr. Assets$17,279$21,175$25,847$29,919
Property Plant & Equip (Net)$25,948$26,569$27,178$27,226
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$2,349$2,348$2,348$2,348
Tax Assets$0$0$15,624$0
Other NC Assets$0$0$2,348$0
Total NC Assets$28,297$28,917$45,150$29,574
Other Assets$0$0$0$0
Total Assets$45,576$50,092$70,997$59,493
Liabilities
Payables$29$47$141$357
Short-Term Debt$4,188$4,016$3,446$3,942
Tax Payable$0$0$418$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$245-$564$79$580
Total Curr. Liab.$4,462$3,499$4,084$4,879
LT Debt$26,895$27,555$56,806$57,602
Deferred Rev, NC$0$0-$28,403$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0-$28,801
Total NC Liab.$26,895$27,555$28,403$28,801
Other Liabilities$0$0$0$0
Cap. Leases$28,989$29,563$30,126$30,772
Total Liabilities$31,357$31,054$48,111$33,680
Equity
Pref Stock$0$0$0$0
Common Stock$2$2$2$2
Retained Earnings-$359,105-$354,271-$350,395-$347,354
AOCI$0$0$0-$0
Other Equity$373,322$373,307$373,279$373,165
Total Equity$14,219$19,038$22,886$25,813
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$45,576$50,092$70,997$59,493
Net Debt$15,048$10,809$35,128$32,765